20-F/A: Cellebrite Amends 20-F Filing to Correct Share Price Trigger for Price Adjustment Shares

Cellebrite files an amendment to its 20-F annual report to correct a typographical error related to the share price triggering event for the issuance of Price Adjustment Shares.

Summary

• Cellebrite DI Ltd. is filing Amendment No. 1 on Form 20-F/A to its Annual Report on Form 20-F for the year ended December 31, 2023.
• The amendment corrects a typographical error in the original filing, changing the share price from $30.00 to $17.50.
• The correction pertains to the third triggering event for the issuance of Price Adjustment Shares to holders of Ordinary Shares and vested RSUs.
• The triggering event is related to the share price performance over a specific trading period.
• The amendment does not update any other information disclosed in the original filing or reflect events occurring after the original filing date.
• The company is also filing certifications required under Section 302 and Section 906 of the Sarbanes-Oxley Act of 2002 as exhibits to this Amendment.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing amendment, indicating a neutral sentiment. The correction of a typo is a standard process.

Future Outlook

The amendment does not contain any forward-looking statements or guidance.

Industry Context

This announcement is a routine correction to a regulatory filing and does not significantly impact the broader industry.

Key Dates

Keywords

20-F/A, Amendment, Price Adjustment Shares, Typographical Error, Share Price, Cellebrite, Ordinary Shares, RSUs